Agilent Product Orders, Revenue Nosedive in Q4; Firm to Cut 4,000 Jobs | GenomeWeb

NEW YORK, Nov. 16 - Agilent Technologies said on Thursday that orders and revenues were slashed by roughly half over last year as the company struggled to regain profitability.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.